Archives

NRTI – Nucleoside Reverse Transcriptase Inhibitor, a type of HIV drug – also called ‘nuke’ or ‘nucleoside analogue’. 3TC (lamivudine). abacavir, AZT, FTC (emtricitabine), d4T (stavudine), ddI (didanosine) all belong to this class. Tenofovir DF and tenofovir alafenamide (TAF) are a …

non-nuke – a common term for NNRTI.

nuke – a common term for NRTI

integrase inhibitor – a type of HIV drug that stops HIV genetic material from ‘integrating’ into the DNA in a cell. This is a relatively new family of HIV drugs. Raltegravir, elvitegravir and dolutegravir are all integrase inhibitors.

PI (protease inhibitor) – a type of HIV drug. HIV protease inhibitors include atazanavir, darunavir, fosamprenavir, indinavir, nelfinavir, lopinavir/r (Kaletra), ritonavir, saquinavir and tipranavir. Drug targets in the virus life cycle Different protease inhibitors have been developed to treat hepatitis C.

Keeping a side effect diary for a few weeks can help in many ways. It can show a pattern to the symptoms that you otherwise were not aware off. It might show more accurately how the symptoms are affecting your …

Switching treatment is much easier than most people think. ART is usually made up of a combination of three active drugs. If one or more of these drugs are causing side effects there are usually alternatives that you can try. …

Post-US election issue: reports from Glasgow Congress and Research for Preventions meetings, global treatment, EACS guidelines, UK PrEP updates and more…

Using generic PrEP bought online – new guide for how to use PrEP safely, including options for dosing…

Introduction This year the biennial Glasgow conference was held from 23-26 October 2016. The meeting has a single-track programme making it easy to attend and follow the whole programme, often highlight important European research before it is presented at CROI, …

First reports from this prevention conference being held in Chicago.

PrEP safety, side effects of integrase inhibitors, HIV and children and global access to dolutegravir – reports from four meetings + other news including reduced dose maintenance studies…

Slovenian Tveganja-za-spolni-prenos-HIVA-in-testiranje (Slovenian) PDF 1.5 Mb

This is a small selection of work that was included in a major art exhibition about HIV – either from artists who were/are HIV positive or from other artists responding to the AIDS crisis. The exhibition included about 300 individual …

Doctor Fax was a publication produced in the UK from June 1996 to January 2000 by the activist organisation AIDS Treatment Project (ATP). The archive is included on the i-Base website because it was produced by the people who then …

News from Durban on HIV prevention including TasP and PrEP, paediatrics, TB and cure research – plus news about PrEP in the UK…

Read this guide online Order a free printed copy Download a PDF version The 7th edition of this guide focuses on the most commonly used and recommended treatments, including new and recently approved drugs. It also new sections on a …

Reports from AIDS 2016 include PrEP and new drugs plus news from the pre-conference paediatric and TB workshops…

Simon Collins, HIV i-Base On 29 July 2016, the PROUD study website announced that the study will close without being able to continue to provide participants with oral PrEP. [1] The press release blames NHS England for cancelling the previous …

Simon Collins, VIH i-Base Los resultados del estudio PARTNER publicados en coincidencia con la conferencia AIDS 2016, que se inaugura en Durban (Sudáfrica) la próxima semana, revelan el impacto del tratamiento antirretroviral en la drástica reducción de la transmisión del …